Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05724693
Status:
COMPLETED
Last Update Posted:
2024-02-02
First Post:
2023-01-24
Brief Title:
Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function
Sponsor:
Atea Pharmaceuticals Inc
Organization:
Atea Pharmaceuticals Inc
Study Overview
Official Title:
A Phase 1 Multicenter Open-Label Parallel-Group Pharmacokinetic Single Dose Study of Bemnifosbuvir AT-527 in Adult Subjects With Normal and Impaired Hepatic Function
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Bemnifosbuvir After a Single Dose
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None